Radicava

— THERAPEUTIC DISORDERS TREATED —
  • Miscellaneous neurodegenerative disorders

Radicava Generic Name & Formulations

General Description

Edaravone 30mg/100mL; soln for IV infusion; contains sodium bisulfite.

Pharmacological Class

Free radical scavenger.

See Also

How Supplied

Single-dose bags—1, 2; ORS Starter Kit (2×35mL)—1 (w. supplies); ORS Kit (1×50mL)—1 (w. supplies)

Generic Availability

NO

Radicava Indications

Indications

Amyotrophic lateral sclerosis (ALS).

Radicava Dosage and Administration

Adult

Give as IV infusion over 60mins. Initial cycle: 60mg (given as two consecutive 30mg infusions) daily for 14 days, followed by 14 days off. Subsequent cycles: 60mg daily for 10 days out of 14-day periods, followed by 14 days off. Switching to ORS: use same dosing frequency.

Children

Not established.

Radicava Contraindications

Not Applicable

Radicava Boxed Warnings

Not Applicable

Radicava Warnings/Precautions

Warnings/Precautions

Monitor for hypersensitivity reactions; discontinue and treat if occur. Asthma. Sulfite sensitivity. Pregnancy. Nursing mothers.

Radicava Pharmacokinetics

See Literature

Radicava Interactions

Radicava Adverse Reactions

Adverse Reactions

Contusion, gait disturbance, headache, dermatitis, eczema, respiratory failure/disorders, hypoxia, glycosuria, tinea infection; hypersensitivity reactions, anaphylaxis.

Radicava Clinical Trials

See Literature

Radicava Note

Not Applicable

Radicava Patient Counseling

See Literature